September 3rd 2024
The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2.
August 23rd 2024
Topics include declining vaccine coverage among kindergarten-aged children and key changes in recommendations for adult vaccination.
Now that the WHO has declared a second mpox global emergency, you may want to brush up on knowledge of the disease and the 2024 outbreak.
August 22nd 2024
The updated COVID-19 vaccines will include a monovalent component corresponding to KP.2, a strain of the Omicron variant of SARS-CoV-2.
August 19th 2024
The First to Know Syphilis Test detects a current or past infection, regardless of successful treatment, in 15 minutes using a drop of blood.
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 18, 2021
Global confirmed cases of COVID-19 have surpassed 95 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 15, 2021
Global COVID-19 mortalities have passed 2 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 14, 2021
US confirmed cases of COVID-19 have surpassed 23 million; global cases have reached 92 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
The COVID-19 Variants: What We Know So Far
What are the implications of the global emergence of SARS-CoV-2 variants in terms of disease severity and vaccine and treatment efficacy?
COVID-19: ACP Releases Statement on Vaccine Provision, Payment
Recommendations address the role of clinicians as vaccinators and stress as essential communication and collaboration with patients' primary care team.
Pfizer & Moderna COVID-19 Vaccines: Side-by-side Comparison
The 2 FDA-approved COVID-19 vaccines are similarly effective but also very different in a number of ways that will affect distribution.
COVID-related Emotions Near an Edge During Holidays
Pandemic conditions are daily life for healthcare professionals, but addressing the distress and despair among friends, family, and colleagues can be a challenge.
Medical Students Augment Accurate Information During Pandemic
Students from the Medical College of Georgia, unable to care directly for COVID-19 patients, combined their individual skills to keep accurate information flowing.
Seen in the ED Quiz: Progressive Buttock Pain
A woman in her forties presents to the ED with 3 days of generalized malaise and worsening pain in the left buttock. What is seen on the CT? Your Dx?
FDA Grants EUA for First Non-prescription, Fully-at-home COVID-19 Test Kit
The rapid antigen test for the detection of active COVID-19 in those with and without symptoms produces results within 20 minutes and will retail for about $30.
Bariatric Surgery May Improve COVID-19 Outcomes in Patients with Obesity
Among patients with obesity who contracted COVID-19, those with a history of bariatric surgery had significantly decreased odds of hospitalization, a new study finds.
How to Manage Post-COVID-19 Vaccination Reactions among Healthcare Staff
Vaccination against COVID-19 for US healthcare personnel began on December 14, 2020; the same day, CDC hosted a webinar on how to ensure HCP health and safety during this period.
State COVID-19 Vaccine Distribution Plans, Priorities
Early COVID-19 vaccine demand will far exceed supply and so states have been refining distribution plans for months. Here is a topline review of what to expect.
Seen in the ED Quiz: Epigastric Pain with Chills, Nausea
The patient denies fever, SOB, vomiting or diarrhea. He does admit discomfort around the right scapula. What is evident on the CT? What is your diagnosis?
High-dose Flu Vaccine Confers No Added Benefit for Patients with CVD
A high-dose influenza vaccine was no more effective than the standard-dose vaccine at reducing the risk of severe outcomes among patients with heart disease, NIH study finds.
CDC Reduces COVID-19 Quarantine Requirement
The CDC reduced the length of quarantine required for persons exposed to someone infected with SARS-CoV-2 from 14 days to 10 or to 7 with a negative test.
Baloxavir Marboxil Wins FDA Label Expansion for Post-exposure Flu Prevention
The expanded indication for baloxavir marboxil is positive news as the surge in US COVID-19 cases converges with the arrival of flu season.
6 Essential COVID-19 Codes to Remember
COVID-19 cases are surging across the country as the US heads into holiday season. Counsel patients on staying safe and keep these billing codes very close at hand.
Moderna COVID-19 Vaccine Candidate Achieves 94.5% Efficacy in Phase 3 Trial
Moderna announced safety and efficacy data from the phase 3 COVE trial that found mRNA-1273 94.5% effective in preventing infection with SARS-CoV-2.
COVID-19 is Not my First Epidemic
The author was a young medical student when the first signs of the HIV epidemic appeared and it shaped his career. How will COVID-19 impact today's young clinicians?
Influenza Coinfection with COVID-19: NIH Treatment Considerations
Recent NIH COVID-19 guideline updates include evidence-based considerations for treatment of patients hospitalized with flu and COVID-19 coinfection.
Hospitalized COVID-19 Patients Have More, More Severe Complications vs Patients with Influenza
The first study to compare COVID-19 and influenza complications in hospitalized patients found COVID-19 patients more likely to be admitted to ICU and to die.
NIH Updates Testing, Treatment Guidelines During Cocirculation of Influenza and COVID-19
The new guideline section stresses that testing is the only way to accurately discriminate between the 2 viruses and advises on influenza vaccination and treatment.
The Presidential COVID-19 Treatment Regimen-to-date
From daily aspirin to RGN-CoV2 to zinc, the president of the United States has been treated for COVID-19 with a wide range of both authorized and unproven therapies.
Study: Antibiotic Prescription Durations for Common Infections Often Exceed Guidelines
Over half of antibiotic courses in a new study exceeded guideline-recommended minimum effective durations, translating to >54 million potentially excessive days.
Navigating the “Perfect Storm”: A COVID-19 Flu Season
The possibility of a flu season wrapped in a global pandemic may have health care professionals especially worried this year.
Genetic Mutations May Underlie Severe COVID-19 Illness
More than 10% of those who develop severe COVID-19 have misguided antibodies that derail the immune response, according to new research.
COVID-19 or the Flu? Preparing for the Overlap
Worried about the upcoming flu season overlapping with COVID-19? Get up to date on available tests and the clinical aspects of the diseases with our quick article.
COVID-19 Vaccine: Pharmaceutical Executives Pledge Safety Above All
CEOs of 9 drug companies involved in COVID-19 vaccine development signed a pledge ensuring that sound science and ethics will guide the process.
3 Influenza Season Imperatives: Vaccinate, Vaccinate, Vaccinate
The CDC estimates delivery of a record 194 to 198 million doses of influenza vaccine this year. The primary care imperative: vaccinate, vaccinate, vaccinate.